デフォルト表紙
市場調査レポート
商品コード
1614874

薬剤給付管理の世界市場規模、シェア、成長分析:サービス別、ビジネスモデル別、エンドユーザー別、地域別 - 産業予測(2024年~2031年)

Pharmacy Benefit Management Market Size, Share, Growth Analysis, By Type (Specialty Pharmacy, Drug Formulatory Management), By Business Model, By End User, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
薬剤給付管理の世界市場規模、シェア、成長分析:サービス別、ビジネスモデル別、エンドユーザー別、地域別 - 産業予測(2024年~2031年)
出版日: 2024年12月14日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の薬剤給付管理の市場規模は、2022年に5,068億米ドルとなり、2023年の5,403億米ドルから2031年には8,742億米ドルに成長し、予測期間中(2024年~2031年)のCAGRは6.2%で成長する見通しです。

薬剤給付管理(PBM)市場は、投薬ミスを減らす需要の高まり、薬局の急速な地域化、高齢化、人件費の増加など、さまざまな要因によって力強い成長を遂げています。PBMは、医薬品処方の管理、リベート交渉、保険会社や薬局の処方薬プログラムの監督など、医薬品サプライチェーンにおいて重要な役割を果たしています。しかし、薬局の自動化技術の導入に対するためらいや、顧客の守秘義務に関する厳しい規制といった課題が、市場の進展を妨げる可能性があります。逆に、コスト削減戦略やPBMサービスのメリットに対する薬剤師や医療提供者の意識の高まりは、予測期間を通じて市場拡大の大きなチャンスとなります。全体として、PBM分野は今後数年間で目覚ましい発展を遂げる準備が整っています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析と影響
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 供給企業の交渉力

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 技術の進歩
  • 規制情勢
  • 特許分析
  • バリューチェーン分析
  • PESTEL分析
  • 市場の魅力指数

薬剤給付管理市場規模:サービス別、CAGR(2024年~2031年)

  • 市場概要
  • 専門薬局
  • 医薬品処方管理
  • 福利厚生プランの設計とコンサルティング
  • その他のサービス

薬剤給付管理市場規模:ビジネスモデル別、CAGR(2024年~2031年)

  • 市場概要
  • 政府の健康プログラム
  • 雇用主の後援プログラム
  • 健康保険管理

薬剤給付管理市場規模:エンドユーザー別、CAGR(2024年~2031年)

  • 市場概要
  • 薬剤給付管理組織
  • 通信販売薬局
  • 小売薬局
  • その他のエンドユーザー

薬剤給付管理市場規模、CAGR(2024年~2031年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比の比較(2021年~2023年)

主要企業プロファイル

  • Express Scripts Holding Company
  • CVS Health Corporation
  • OptumRx, Inc.
  • Prime Therapeutics LLC
  • Humana Pharmacy Solutions, Inc.
  • MedImpact Healthcare Systems, Inc.
  • Magellan Health, Inc.
  • Cigna Corporation
  • Aetna Inc.
  • Anthem, Inc.
  • UnitedHealth Group Incorporated
  • WellDyneRx, LLC
  • Navitus Health Solutions, LLC
  • PerformRx, LLC
  • EnvisionRxOptions, LLC
  • IngenioRx, Inc.
  • Argus Health Systems, Inc.
  • ScriptCare, Ltd.
  • Catalyst Rx, Inc.
  • Curascript Specialty Distribution, Inc.

結論と推奨事項

目次
Product Code: SQMIG45I2098

Global Pharmacy Benefit Management Market size was valued at USD 506.8 billion in 2022 and is poised to grow from USD 540.3 billion in 2023 to USD 874.2 billion by 2031, growing at a CAGR of 6.2% during the forecast period (2024-2031).

The Pharmacy Benefit Management (PBM) market is experiencing robust growth driven by various factors, including the rising demand for reducing medication errors, the rapid regionalization of pharmacies, an aging population, and increasing labor costs. PBMs play a critical role in the pharmaceutical supply chain, managing drug formularies, negotiating rebates, and overseeing prescription drug programs for insurers and pharmacies. However, challenges such as hesitance to adopt pharmacy automation technologies and stringent regulations on client confidentiality may hinder market progress. Conversely, heightened awareness among pharmacists and healthcare providers about the benefits of cost-reduction strategies and PBM services presents significant opportunities for market expansion throughout the forecast period. Overall, the PBM sector is poised for remarkable development in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmacy Benefit Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmacy Benefit Management Market Segmental Analysis

Global Pharmacy Benefit Management Market is segmented by Services, Business Model, End User and Region. Based on Services, the market is segmented into specialty pharmacy, drug formulatory management, benefit plan design & consultation and other services. Based on Business Model, the market is segmented into Government Health Programs, Employer-Sponsored Programs, and Health Insurance Management. Based on End Users, the market is segmented into pharmacy benefit management organization, mail order pharmacies, retail pharmacies, and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmacy Benefit Management Market

The Global Pharmacy Benefit Management market is experiencing significant growth due to escalating pharmaceutical costs driven by the rising incidence of chronic diseases worldwide. As chronic conditions such as cardiovascular disease and chronic lung disease become more prevalent, there is an increasing demand for effective treatment options. This trend has prompted major pharmaceutical companies to develop high-priced branded medications, leading to an unprecedented surge in drug expenditures. Consequently, the soaring healthcare costs associated with an uptick in prescription registrations create a substantial financial burden. This scenario drives the demand for pharmacy benefit management services, which aim to mitigate drug expenses and regulate pharmaceutical spending on a global scale, facilitating market expansion.

Restraints in the Global Pharmacy Benefit Management Market

The Global Pharmacy Benefit Management market faces significant restraints due to a lack of transparency regarding profit earnings, which hinders widespread adoption. While rising medication costs and increased prescription filings globally are contributing to market growth, concerns about the opacity of business models within pharmacy benefit management services remain a persistent issue. The revenue streams of these services are often undisclosed to insurance providers, retail pharmacies, and pharmaceutical manufacturers, resulting in substantial medication costs being transferred to service providers. Consequently, both drug manufacturers and insurers are experiencing notable declines in profits, leading many insurers to form limited partnerships with pharmacy benefit managers. This situation contributes to a slow adoption rate of these services, which is anticipated to restrain market growth throughout the study period.

Market Trends of the Global Pharmacy Benefit Management Market

The Global Pharmacy Benefit Management (PBM) market is undergoing a significant transformation driven by the adoption of machine learning technologies, which streamline operations and enhance service delivery. As insurance companies, retail pharmacy chains, and drug manufacturers increasingly embrace PBM services, there is a notable shift from traditional workflows to advanced, data-driven processes. This transition facilitates a more efficient supply chain, accelerates mail order delivery, and enables service providers to cater to a broader range of insurance plans and pharmacy networks quickly. Consequently, this trend not only improves operational efficiency but also enhances customer satisfaction, positioning machine learning as a critical component of PBM evolution.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • PESTEL Analysis
  • Market Attractiveness Index

Global Pharmacy Benefit Management Market Size by Services & CAGR (2024-2031)

  • Market Overview
  • Specialty Pharmacy
  • Drug Formulatory Management
  • Benefit Plan Design and Consultation
  • Other Services

Global Pharmacy Benefit Management Market Size by Business Model & CAGR (2024-2031)

  • Market Overview
  • Government Health Programs
  • Employer-Sponsored Programs
  • Health Insurance Management

Global Pharmacy Benefit Management Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Pharmacy Benefit Management Organization
  • Mail Order Pharmacies
  • Retail Pharmacies
  • Other End Users Source

Global Pharmacy Benefit Management Market Size & CAGR (2024-2031)

  • North America (Services, Business Model, End-User)
    • US
    • Canada
  • Europe (Services, Business Model, End-User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Services, Business Model, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Services, Business Model, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Services, Business Model, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Express Scripts Holding Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CVS Health Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OptumRx, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prime Therapeutics LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Humana Pharmacy Solutions, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedImpact Healthcare Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Magellan Health, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cigna Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aetna Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anthem, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • UnitedHealth Group Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • WellDyneRx, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Navitus Health Solutions, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerformRx, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EnvisionRxOptions, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IngenioRx, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Argus Health Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ScriptCare, Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Catalyst Rx, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Curascript Specialty Distribution, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation